Neoadjuvant Chemotherapy

Neoadjuvant chemotherapy stands as a pivotal strategy in modern cancer research and treatment paradigms. Unlike traditional chemotherapy given after surgery, neoadjuvant therapy administers drugs prior to surgical intervention. This approach serves multiple purposes. Firstly, it aims to shrink tumors, making them more operable and potentially increasing the likelihood of complete surgical resection. Secondly, it provides an opportunity to assess tumor response to specific drugs, aiding in treatment tailoring for individual patients. Additionally, neoadjuvant chemotherapy can serve as a "real-time" test for drug efficacy, offering valuable insights into tumor biology and drug resistance mechanisms. By integrating chemotherapy into the preoperative phase, this approach represents a dynamic tool in the quest for more personalized and effective cancer care.